These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29363217)

  • 41. Changes in Pain Sensitivity and Pain Modulation During Oral Opioid Treatment: The Impact of Negative Affect.
    Edwards RR; Dolman AJ; Michna E; Katz JN; Nedeljkovic SS; Janfaza D; Isaac Z; Martel MO; Jamison RN; Wasan AD
    Pain Med; 2016 Oct; 17(10):1882-1891. PubMed ID: 26933094
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prediction of postoperative opioid analgesia using clinical-experimental parameters and electroencephalography.
    Gram M; Erlenwein J; Petzke F; Falla D; Przemeck M; Emons MI; Reuster M; Olesen SS; Drewes AM
    Eur J Pain; 2017 Feb; 21(2):264-277. PubMed ID: 27470494
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The hypoalgesic effect of imipramine in different human experimental pain models.
    Poulsen L; Arendt-Nielsen L; Brøsen K; Nielsen KK; Gram LF; Sindrup SH
    Pain; 1995 Mar; 60(3):287-93. PubMed ID: 7596624
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term Safety and Efficacy of Tapentadol Extended Release Following up to 2 Years of Treatment in Patients With Moderate to Severe, Chronic Pain: Results of an Open-label Extension Trial.
    Buynak R; Rappaport SA; Rod K; Arsenault P; Heisig F; Rauschkolb C; Etropolski M
    Clin Ther; 2015 Nov; 37(11):2420-38. PubMed ID: 26428249
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of naproxen with cyclobenzaprine, oxycodone-acetaminophen, and placebo for the treatment of acute low back pain.
    Gottlieb M; Njie A
    CJEM; 2016 Nov; 18(6):491-494. PubMed ID: 27640607
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of the extended-release tramadol hydrochloride/acetaminophen fixed-dose combination tablet for the treatment of chronic low back pain.
    Lee JH; Lee CS;
    Clin Ther; 2013 Nov; 35(11):1830-40. PubMed ID: 24183364
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Contributions of mood, pain catastrophizing, and cold hyperalgesia in acute and chronic low back pain: a comparison with pain-free controls.
    Hübscher M; Moloney N; Rebbeck T; Traeger A; Refshauge KM
    Clin J Pain; 2014 Oct; 30(10):886-93. PubMed ID: 24145929
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fentanyl buccal tablet compared with immediate-release oxycodone for the management of breakthrough pain in opioid-tolerant patients with chronic cancer and noncancer pain: a randomized, double-blind, crossover study followed by a 12-week open-label phase to evaluate patient outcomes.
    Webster LR; Slevin KA; Narayana A; Earl CQ; Yang R
    Pain Med; 2013 Sep; 14(9):1332-45. PubMed ID: 23855816
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Longitudinal observation of changes in pain sensitivity during opioid tapering in patients with chronic low-back pain.
    Wang H; Akbar M; Weinsheimer N; Gantz S; Schiltenwolf M
    Pain Med; 2011 Dec; 12(12):1720-6. PubMed ID: 22082225
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Do chronic low back pain subgroups derived from dynamic quantitative sensory testing exhibit differing multidimensional profiles?
    Rabey M; Kendell M; Koren S; Silva I; Watts L; Wong C; Slater H; Smith A; Beales D
    Scand J Pain; 2021 Jul; 21(3):474-484. PubMed ID: 33639047
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analgesic efficacy and tolerability of intravenous morphine versus combined intravenous morphine and oxycodone in a 2-center, randomized, double-blind, pilot trial of patients with moderate to severe pain after total hip replacement.
    Joppich R; Richards P; Kelen R; Stern W; Zarghooni K; Otto C; Böhmer A; Petzke F; Treptau T; Lefering R; Bäthis H; Neugebauer E
    Clin Ther; 2012 Aug; 34(8):1751-60. PubMed ID: 22795613
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term efficacy and safety of oxycodone-naloxone prolonged release in geriatric patients with moderate-to-severe chronic noncancer pain: a 52-week open-label extension phase study.
    Guerriero F; Roberto A; Greco MT; Sgarlata C; Rollone M; Corli O
    Drug Des Devel Ther; 2016; 10():1515-23. PubMed ID: 27143857
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reliability of Quantitative Sensory Tests in a Low Back Pain Population.
    Vuilleumier PH; Biurrun Manresa JA; Ghamri Y; Mlekusch S; Siegenthaler A; Arendt-Nielsen L; Curatolo M
    Reg Anesth Pain Med; 2015; 40(6):665-73. PubMed ID: 26222349
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The use of a battery of pain models to detect analgesic properties of compounds: a two-part four-way crossover study.
    Okkerse P; van Amerongen G; de Kam ML; Stevens J; Butt RP; Gurrell R; Dahan A; van Gerven JM; Hay JL; Groeneveld GJ
    Br J Clin Pharmacol; 2017 May; 83(5):976-990. PubMed ID: 27862179
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Topographic mapping of pain sensitivity of the lower back - a comparison of healthy controls and patients with chronic non-specific low back pain.
    O'Neill S; Larsen JB; Nim C; Arendt-Nielsen L
    Scand J Pain; 2019 Jan; 19(1):25-37. PubMed ID: 30260794
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A comparative study of oxycodone and morphine in a multi-modal, tissue-differentiated experimental pain model.
    Staahl C; Christrup LL; Andersen SD; Arendt-Nielsen L; Drewes AM
    Pain; 2006 Jul; 123(1-2):28-36. PubMed ID: 16600508
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oxycodone for neuropathic pain and fibromyalgia in adults.
    Gaskell H; Moore RA; Derry S; Stannard C
    Cochrane Database Syst Rev; 2014 Jun; (6):CD010692. PubMed ID: 24956205
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical evaluation of the first oxycodone once daily prolonged release tablet in moderate to severe chronic pain: a randomized, double-blind, multicenter, cross-over, non-inferiority study to investigate efficacy and safety in comparison with an established oxycodone twice daily prolonged release tablet.
    Lux EA; Janecki M; Maritz MA
    Curr Med Res Opin; 2014 Nov; 30(11):2365-75. PubMed ID: 25050592
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased pain sensitivity in chronic pain subjects on opioid therapy: a cross-sectional study using quantitative sensory testing.
    Zhang Y; Ahmed S; Vo T; St Hilaire K; Houghton M; Cohen AS; Mao J; Chen L
    Pain Med; 2015 May; 16(5):911-22. PubMed ID: 25376890
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A randomized, double-blind, placebo-controlled study of oral oxycodone plus acetaminophen for the treatment of pain in photodynamic therapy on port wine stains.
    Huang N; Zeng J; Liang J; Qiu H; Wang Y; Gu Y
    Photodiagnosis Photodyn Ther; 2014 Jun; 11(2):134-40. PubMed ID: 24642191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.